These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 25738817

  • 1. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J, Nix EB, Gaultier GN, Cox AD, McCready W, Ulanova M.
    Vaccine; 2015 Apr 15; 33(16):1941-7. PubMed ID: 25738817
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN, Kaur R, Pichichero ME.
    FEMS Immunol Med Microbiol; 2012 Aug 15; 65(3):439-47. PubMed ID: 22463053
    [Abstract] [Full Text] [Related]

  • 3. Sialic Acid Protects Nontypeable Haemophilus influenzae from Natural IgM and Promotes Survival in Murine Respiratory Tract.
    Jackson MD, Wong SM, Akerley BJ.
    Infect Immun; 2021 May 17; 89(6):. PubMed ID: 33782153
    [Abstract] [Full Text] [Related]

  • 4. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae.
    Gu XX, Rudy SF, Chu C, McCullagh L, Kim HN, Chen J, Li J, Robbins JB, Van Waes C, Battey JF.
    Vaccine; 2003 May 16; 21(17-18):2107-14. PubMed ID: 12706701
    [Abstract] [Full Text] [Related]

  • 5. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.
    Sun J, Chen J, Cheng Z, Robbins JB, Battey JF, Gu XX.
    Vaccine; 2000 Jan 18; 18(13):1264-72. PubMed ID: 10649628
    [Abstract] [Full Text] [Related]

  • 6. Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement.
    Jackson MD, Wong SM, Akerley BJ.
    Infect Immun; 2019 Nov 18; 87(11):. PubMed ID: 31405955
    [Abstract] [Full Text] [Related]

  • 7. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.
    Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SP, Burghout P, Diavatopoulos DA, Hermans PW.
    mBio; 2012 Nov 18; 3(4):e00079-12. PubMed ID: 22761391
    [Abstract] [Full Text] [Related]

  • 8. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
    Hou Y, Gu XX.
    J Immunol; 2003 Apr 15; 170(8):4373-9. PubMed ID: 12682274
    [Abstract] [Full Text] [Related]

  • 9. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    Nix EB, Choi J, Anthes C, Gaultier GN, Thorgrimson J, Cox AD, Tsang RSW, McCready WG, Boreham D, Ulanova M.
    PLoS One; 2018 Apr 15; 13(8):e0201282. PubMed ID: 30110339
    [Abstract] [Full Text] [Related]

  • 10. Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.
    Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M.
    Emerg Infect Dis; 2015 Feb 15; 21(2):273-9. PubMed ID: 25626129
    [Abstract] [Full Text] [Related]

  • 11. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.
    Ueyama T, Gu XX, Tsai CM, Karpas AB, Lim DJ.
    Clin Diagn Lab Immunol; 1999 Jan 15; 6(1):96-100. PubMed ID: 9874671
    [Abstract] [Full Text] [Related]

  • 12. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.
    Vaccine; 2005 Jan 26; 23(10):1294-300. PubMed ID: 15652672
    [Abstract] [Full Text] [Related]

  • 13. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S, Wilson JC, Cripps AW, Massa H, Ozberk V, Grice ID, Peak IR.
    Vaccine; 2020 Jan 10; 38(2):309-317. PubMed ID: 31668366
    [Abstract] [Full Text] [Related]

  • 14. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE, Pelton SI, Gulati S, Rice PA.
    J Clin Invest; 1985 May 10; 75(5):1645-58. PubMed ID: 3873475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A, Ahmed HJ, Van Dyck E, Lagergård T.
    Microb Pathog; 1998 Aug 10; 25(2):67-75. PubMed ID: 9712686
    [Abstract] [Full Text] [Related]

  • 18. Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.
    Langereis JD, van der Pasch ES, de Jonge MI.
    Infect Immun; 2019 Aug 10; 87(8):. PubMed ID: 31109949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.